1. Home
  2. ICCC vs MAXN Comparison

ICCC vs MAXN Comparison

Compare ICCC & MAXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCC
  • MAXN
  • Stock Information
  • Founded
  • ICCC 1982
  • MAXN 2019
  • Country
  • ICCC United States
  • MAXN Singapore
  • Employees
  • ICCC N/A
  • MAXN N/A
  • Industry
  • ICCC Biotechnology: Pharmaceutical Preparations
  • MAXN Semiconductors
  • Sector
  • ICCC Health Care
  • MAXN Technology
  • Exchange
  • ICCC Nasdaq
  • MAXN Nasdaq
  • Market Cap
  • ICCC 60.1M
  • MAXN 56.0M
  • IPO Year
  • ICCC 1987
  • MAXN N/A
  • Fundamental
  • Price
  • ICCC $6.46
  • MAXN $4.34
  • Analyst Decision
  • ICCC
  • MAXN Sell
  • Analyst Count
  • ICCC 0
  • MAXN 1
  • Target Price
  • ICCC N/A
  • MAXN $4.00
  • AVG Volume (30 Days)
  • ICCC 16.1K
  • MAXN 213.1K
  • Earning Date
  • ICCC 08-14-2025
  • MAXN 09-02-2025
  • Dividend Yield
  • ICCC N/A
  • MAXN N/A
  • EPS Growth
  • ICCC N/A
  • MAXN N/A
  • EPS
  • ICCC N/A
  • MAXN N/A
  • Revenue
  • ICCC $27,302,766.00
  • MAXN $509,048,000.00
  • Revenue This Year
  • ICCC N/A
  • MAXN $100.37
  • Revenue Next Year
  • ICCC N/A
  • MAXN $24.61
  • P/E Ratio
  • ICCC N/A
  • MAXN N/A
  • Revenue Growth
  • ICCC 28.29
  • MAXN N/A
  • 52 Week Low
  • ICCC $3.34
  • MAXN $2.49
  • 52 Week High
  • ICCC $7.60
  • MAXN $23.11
  • Technical
  • Relative Strength Index (RSI)
  • ICCC 47.42
  • MAXN 58.70
  • Support Level
  • ICCC $6.25
  • MAXN $4.28
  • Resistance Level
  • ICCC $7.30
  • MAXN $4.97
  • Average True Range (ATR)
  • ICCC 0.34
  • MAXN 0.45
  • MACD
  • ICCC -0.03
  • MAXN 0.06
  • Stochastic Oscillator
  • ICCC 20.00
  • MAXN 64.41

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About MAXN Maxeon Solar Technologies Ltd.

Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, France, Italy, and others.

Share on Social Networks: